Log in
Sign Up. It's Free
Last Update: Oct, 21 2024
Overview
Dosage & Administration
Drug label
PubMed™ News
FAQ
Lumoxiti
(moxetumomab pasudotox-tdfk)
LUMOXITI 1 MG Injection
BOXED WARNING
Dosage & Administration
* Recommended dosage: 0.04 mg/kg as an intravenous infusion over 30 minutes on Days 1, 3, and 5 of each 28-day cycle. (2.1)
* Maintain adequate hydration throughout treatment. (2.2)
* Consider low-dose aspirin on Days 1 to 8 of each 28-day cycle. (2.2)
* Premedicate with an acetaminophen antipyretic, antihistamine, and H2-receptor antagonist prior to all infusions. (2.2)
* See full prescribing information for instructions on reconstitution of lyophilized cake or powder, and preparation and administration of reconstituted drug. (2.4)
Lumoxiti Prescribing Information
Report Adverse Event
Lumoxiti PubMed™ News
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
Lumoxiti FAQs
How is the dosage of Lumoxiti?
Lumoxiti is available in 1 dosages, including 1 mg Injection
What does Lumoxiti treat?
Lumoxiti treats Leukemia, Hairy Cell
How Is Lumoxiti Administered?
Lumoxiti is administered as a Injectable
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
